TREM2 and Alzheimer disease: A more recent single-nucleus transcriptomic study conducted both tissue from 5XFAD mice and AD patients with TREM2 mutations found that transcriptional signatures in human AD in microglia, astrocytes and oligodendrocytes were strikingly different from those observed in mice [442].